Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-12-30

FDA Approved: IVABRADINE — Original Application (Ingenus Pharmaceuticals, LLC)

View source ↗

Summary

FDA approved the original ANDA for IVABRADINE, allowing Ingenus Pharmaceuticals, LLC to market a generic form of ivabradine in the United States.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • IVABRADINE

Snippet

ORIG AP for IVABRADINE (IVABRADINE)